Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2010 1
2013 2
2015 1
2016 1
2018 8
2019 2
2020 4
2021 9
2022 14
2023 19
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean jilin jiang (2 results)?
Optimized Cytogenetic Risk-Group Stratification of KMT2A-Rearranged Pediatric Acute Myeloid Leukemia.
van Weelderen RE, Harrison CJ, Klein K, Jiang Y, Abrahamsson J, Alonzo T, Aplenc R, Arad-Cohen N, Bart-Delabesse E, Buldini B, De Moerloose B, Dworzak MN, Elitzur S, Fernández Navarro JM, Gamis AS, Gerbing RB, Goemans BF, de Groot-Kruseman HA, Guest EM, Ha SY, Hasle H, Kelaidi C, Lapillonne H, Leverger G, Locatelli F, Miyamura T, Noren-Nystrom U, Polychronopoulou S, Rasche M, Rubnitz JE, Stary J, Tierens A, Tomizawa D, Zwaan MC, Kaspers GJL. van Weelderen RE, et al. Among authors: jiang y. Blood Adv. 2024 Apr 15:bloodadvances.2023011771. doi: 10.1182/bloodadvances.2023011771. Online ahead of print. Blood Adv. 2024. PMID: 38621200
Synergistic Combination of Sb2Si2Te6 Additives for Enhanced Average ZT and Single-Leg Device Efficiency of Bi0.4Sb1.6Te3-based Composites.
Tan XY, Dong J, Liu J, Zhang D, Solco SFD, Sağlık K, Jia N, You IJWJ, Chien SW, Wang X, Hu L, Luo Y, Zheng Y, Soo DXY, Ji R, Goh KCH, Jiang Y, Li JF, Suwardi A, Zhu Q, Xu J, Yan Q. Tan XY, et al. Among authors: jiang y. Adv Sci (Weinh). 2024 Mar 29:e2400870. doi: 10.1002/advs.202400870. Online ahead of print. Adv Sci (Weinh). 2024. PMID: 38553790
Highly stabilized and efficient thermoelectric copper selenide.
Hu H, Ju Y, Yu J, Wang Z, Pei J, Thong HC, Li JW, Cai B, Liu F, Han Z, Su B, Zhuang HL, Jiang Y, Li H, Li Q, Zhao H, Zhang BP, Zhu J, Li JF. Hu H, et al. Among authors: jiang y. Nat Mater. 2024 Apr;23(4):527-534. doi: 10.1038/s41563-024-01815-1. Epub 2024 Mar 7. Nat Mater. 2024. PMID: 38454027
Inotuzumab ozogamicin combined with chemotherapy in pediatric B-cell precursor CD22+ acute lymphoblastic leukemia: results of the phase IB ITCC-059 trial.
Pennesi E, Brivio E, Ammerlaan ACJ, Jiang Y, Van der Velden VHJ, Beverloo HB, Sleight B, Locatelli F, Brethon B, Rossig C, Engstler G, Nilsson A, Bruno B, Petit A, Bielorai B, Rizzari C, Rialland F, Rubio-San-Simón A, Sirvent FJB, Diaz-de-Heredia C, Rives S, Zwaan CM. Pennesi E, et al. Among authors: jiang y. Haematologica. 2024 Jan 4. doi: 10.3324/haematol.2023.284409. Online ahead of print. Haematologica. 2024. PMID: 38186333 Free article.
Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921.
Brivio E, Pennesi E, Willemse ME, Huitema ADR, Jiang Y, van Tinteren HDR, van der Velden VHJ, Beverloo BH, den Boer ML, Rammeloo LAJ, Hudson C, Heerema N, Kowalski K, Zhao H, Kuttschreuter L, Bautista Sirvent FJ, Bukowinski A, Rizzari C, Pollard J, Murillo-Sanjuán L, Kutny M, Zarnegar-Lumley S, Redell M, Cooper S, Bertrand Y, Petit A, Krystal J, Metzler M, Lancaster D, Bourquin JP, Motwani J, van der Sluis IM, Locatelli F, Roth ME, Hijiya N, Zwaan CM. Brivio E, et al. Among authors: jiang y. J Clin Oncol. 2024 Mar 1;42(7):821-831. doi: 10.1200/JCO.23.00897. Epub 2023 Nov 30. J Clin Oncol. 2024. PMID: 38033284 Free PMC article. Clinical Trial.
65 results